Viewing Study NCT00754351


Ignite Creation Date: 2025-12-24 @ 11:52 PM
Ignite Modification Date: 2026-01-07 @ 7:11 AM
Study NCT ID: NCT00754351
Status: COMPLETED
Last Update Posted: 2012-06-28
First Post: 2008-09-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast Cancer
Sponsor: University Hospital of Crete
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None docetaxel View
None gemcitabine View
None bevacizumab View
None chemotherapy View